Applied Therapeutics Inc (NASDAQ: APLT) kicked off on Tuesday, up 0.40% from the previous trading day, before settling in for the closing price of $0.42. Over the past 52 weeks, APLT has traded in a range of $0.29-$10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 26.57%. While this was happening, its average annual earnings per share was recorded 21.05%. With a float of $116.52 million, this company’s outstanding shares have now reached $141.58 million.
Considering the fact that the conglomerate employs 35 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 24.15%, operating margin of -41030.19%, and the pretax margin is -16419.25%.
Applied Therapeutics Inc (APLT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 17.70%, while institutional ownership is 74.84%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 21.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.56% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Take a look at Applied Therapeutics Inc’s (APLT) current performance indicators. Last quarter, stock had a quick ratio of 3.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 221.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.43, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Compared to the last year’s volume of 2.94 million, its volume of 2.28 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 91.75%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 37.23%, which indicates a significant decrease from 88.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0407 in the past 14 days, which was lower than the 0.0462 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3889, while its 200-day Moving Average is $2.4890. Nevertheless, the first resistance level for the watch stands at $0.4605 in the near term. At $0.4982, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5585. If the price goes on to break the first support level at $0.3625, it is likely to go to the next support level at $0.3022. Should the price break the second support level, the third support level stands at $0.2645.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
The company with the Market Capitalisation of 59.84 million has total of 141,576K Shares Outstanding. Its annual sales at the moment are 460 K in contrast with the sum of -105,620 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was 44,010 K.
